{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:55:16Z","timestamp":1790801716644,"version":"4.1.0"},"reference-count":33,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100006342","name":"Association Vaincre la Mucoviscidose","doi-asserted-by":"crossref","award":["RF20200502688"],"award-info":[{"award-number":["RF20200502688"]}],"id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Association Gregory Lemarchal","award":["RF20200502688"],"award-info":[{"award-number":["RF20200502688"]}]},{"name":"Sant\u00e9 publique France"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2024,1,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Murepavadin is a peptidomimetic exhibiting specific inhibitory activity against\n            <jats:italic>Pseudomonas<\/jats:italic>\n            species. In the present study, its\n            <jats:italic>in vitro<\/jats:italic>\n            activity was assessed on 230 cystic fibrosis (CF) strains of\n            <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n            isolated from 12 French hospitals, in comparison with 12 other antipseudomonal antibiotics. Although murepavadin is still in preclinical stage of development, 9.1% (\n            <jats:italic>n<\/jats:italic>\n            = 21) of strains had a minimum inhibitory concentration (MIC) &gt;4 mg\/L, a level at least 128-fold higher than the modal MIC value of the whole collection (\u22640.06 mg\/L). Whole-genome sequencing of these 21 strains along with more susceptible isogenic counterparts coexisting in the same patients revealed diverse mutations in genes involved in the synthesis (\n            <jats:italic>lpxL1<\/jats:italic>\n            and\n            <jats:italic>lpxL2<\/jats:italic>\n            ) or transport of lipopolysaccharides (\n            <jats:italic>bamA<\/jats:italic>\n            ,\n            <jats:italic>lptD<\/jats:italic>\n            , and\n            <jats:italic>msbA<\/jats:italic>\n            ), or encoding histidine kinases of two-component systems (\n            <jats:italic>pmrB<\/jats:italic>\n            and\n            <jats:italic>cbrA<\/jats:italic>\n            ). Allelic replacement experiments with wild-type reference strain PAO1 confirmed that alteration of genes\n            <jats:italic>lpxL1<\/jats:italic>\n            ,\n            <jats:italic>bamA,<\/jats:italic>\n            and\/or\n            <jats:italic>pmrB<\/jats:italic>\n            can decrease the murepavadin susceptibility from 8- to 32-fold. Furthermore, we found that specific amino acid substitutions in histidine kinase PmrB (G188D, Q105P, and D45E) reduce the susceptibility of\n            <jats:italic>P. aeruginosa<\/jats:italic>\n            to murepavadin, colistin, and tobramycin, three antibiotics used or intended to be used (murepavadin) in aerosols to treat colonized CF patients. Whether colistin or tobramycin may select mutants resistant to murepavadin or the opposite needs to be addressed by clinical studies.\n          <\/jats:p>","DOI":"10.1128\/aac.01298-23","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T14:04:06Z","timestamp":1702303446000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":10,"title":["Mutations in genes\n            <i>lpxL1<\/i>\n            ,\n            <i>bamA<\/i>\n            , and\n            <i>pmrB<\/i>\n            impair the susceptibility of cystic fibrosis strains of\n            <i>Pseudomonas aeruginosa<\/i>\n            to murepavadin"],"prefix":"10.1128","volume":"68","author":[{"given":"Aya","family":"Ghassani","sequence":"first","affiliation":[{"name":"UMR6249 CNRS Chrono-environnement, Universit\u00e9 de Franche-Comt\u00e9 , Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Triponney","sequence":"additional","affiliation":[{"name":"Laboratoire associ\u00e9 au Centre National de R\u00e9f\u00e9rence de la r\u00e9sistance aux antibiotiques , Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Bour","sequence":"additional","affiliation":[{"name":"Laboratoire associ\u00e9 au Centre National de R\u00e9f\u00e9rence de la r\u00e9sistance aux antibiotiques , Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7381-5671","authenticated-orcid":false,"given":"Patrick","family":"Pl\u00e9siat","sequence":"additional","affiliation":[{"name":"UMR6249 CNRS Chrono-environnement, Universit\u00e9 de Franche-Comt\u00e9 , Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4634-8550","authenticated-orcid":false,"given":"Katy","family":"Jeannot","sequence":"additional","affiliation":[{"name":"UMR6249 CNRS Chrono-environnement, Universit\u00e9 de Franche-Comt\u00e9 , Besan\u00e7on, France"},{"name":"Laboratoire associ\u00e9 au Centre National de R\u00e9f\u00e9rence de la r\u00e9sistance aux antibiotiques , Besan\u00e7on, France"},{"name":"Laboratoire de Bact\u00e9riologie, Centre Hospitalier Universitaire Jean Minjoz , Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MucoMicrobes study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Cardot-Martin","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire Foch , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cattoir","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Rennes , Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Cr\u00e9met","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Nantes , Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Dol\u00e9an-Jordheim","sequence":"additional","affiliation":[{"name":"Hospices civils de Lyon , Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Ferroni","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Necker , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Garnier","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Limoges , Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Guet-Revillet","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Toulouse , Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Guillard","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Reims , Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Hery-Arnaud","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Brest , Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gueni\u00e8vre","family":"Imbert","sequence":"additional","affiliation":[{"name":"Centre Hospitalier de Toulon , Toulon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mariani","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire Robert Debr\u00e9 , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00138-18"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201207-1160OE"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2018.02.006"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1182749"},{"key":"e_1_3_3_6_2","unstructured":"Spexis . 2023. Spexis. Inhaled murepavadin. Available from: https:\/\/spexisbio.com\/pol7080\/. Retrieved 17 Aug 2023."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.201200276"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.7b00822"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2019.00045"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00311-18"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky227"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01541-19"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00040-09"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01699-18"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa529"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00511-19"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03570.x"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2010.08.004"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.01050-12"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5469.1251"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/1753425909106436"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftv053"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-90-481-9078-2_11"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00911-10"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01044-19"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05829-11"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M702952200"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01142-18"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00036-10"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1179\/096805103225002764"},{"key":"e_1_3_3_32_2","volume-title":"Clinical laboratory testing and in vitro diagnostic test systems_susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices. ISO 207776-2","unstructured":"Clinical laboratory testing and in vitro diagnostic test systems_susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices. ISO 207776-2. AFNOR, Gen\u00e8ve."},{"key":"e_1_3_3_33_2","unstructured":"The European Committee on Antimicrobial Susceptibility Testing . 2023. Breakpoint tables for interpretation of MICs and zone diameters. Version 13.0. http:\/\/www.eucast.org."},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(91)90599-7"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.12.7347"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01298-23","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01298-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T23:38:30Z","timestamp":1715816310000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.01298-23"}},"subtitle":[],"editor":[{"given":"Laurent","family":"Poirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,10]]}},"alternative-id":["10.1128\/aac.01298-23"],"URL":"https:\/\/doi.org\/10.1128\/aac.01298-23","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,10]]},"assertion":[{"value":"2023-10-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01298-23"}}